Michael Nofi

CFO

Equibles does not estimate personal net worth.

About Michael Nofi

Michael Nofi is recorded as CFO at Edgewise Therapeutics, Inc. (EWTX) since November 10, 2025. Edgewise Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Michael Nofi was appointed Chief Financial Officer, effective November 10, 2025. Edgewise Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edgewise Therapeutics, Inc. includes Kevin Koch (CEO and Board Member), Michael P. Nofi (CFO), R. Michael Carruthers (CFO) and 6 others.

“On November 10, 2025, Edgewise Therapeutics, Inc. (the "Company") announced the appointment of Michael Nofi as the Company's Chief Financial Officer, effective November 10, 2025.”

Edgewise Therapeutics, Inc. Form 8-K, filed November 10, 2025 · Read the filing

Affiliation history

Edgewise Therapeutics, Inc. (EWTX)
CFO

SEC 8-K

Current
2025-11-10–present

Company network

Edgewise Therapeutics, Inc.

EWTX

Current role

Biotechnology · Healthcare

CFO

2025-11-10–present

Leadership on record at Edgewise Therapeutics, Inc.

Kevin Koch CEO, Board Member
Michael P. Nofi CFO
R. Michael Carruthers CFO
Behrad Derakhshan COO
Alan Russell Board Member
Christopher Martin Board Member
Dr. Jonathan Fox Board Member
Jonathan Root Board Member
Laura Brege Board Member

Recent activity

Executive change Appointed: Chief Financial Officer Edgewise Therapeutics, Inc. (EWTX)
2025-11-10